Vcreate

Vcreate is the developer of a biotechnology research platform designed to create the next generation of T-cell immunotherapies. The company's platform is committed to combining novel high-throughput screening assays and machine learning to design the next generation of cancer immunotherapies, enabling patients to accelerate the development of T-cell receptors for solid tumors.